SKIN KAPOSI SARCOMA
Clinical trials for SKIN KAPOSI SARCOMA explained in plain language.
Never miss a new study
Get alerted when new SKIN KAPOSI SARCOMA trials appear
Sign up with your email to follow new studies for SKIN KAPOSI SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise in blocking kaposi sarcoma growth
Disease control CompletedThis study tested a drug called sEphB4-HSA in 23 people with Kaposi sarcoma, a type of skin cancer. The drug works by stopping blood vessels from feeding the cancer and may also slow cancer cell growth. The goal was to see how many patients responded to treatment and to check for…
Matched conditions: SKIN KAPOSI SARCOMA
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Could a cancer drug tame kaposi sarcoma in HIV patients?
Disease control CompletedThis completed Phase II trial tested the drug pomalidomide in 26 HIV-positive adults with Kaposi sarcoma, a type of skin cancer common in Sub-Saharan Africa. Pomalidomide works by boosting the immune system and blocking blood vessel growth that feeds tumors. Researchers measured …
Matched conditions: SKIN KAPOSI SARCOMA
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Could an old HIV drug beat kaposi sarcoma?
Disease control CompletedThis pilot phase 2 trial tested the HIV drug nelfinavir in 36 people with Kaposi sarcoma, a type of cancer. The goal was to see if the drug could shrink or eliminate skin lesions. Researchers looked at how well the drug worked in both HIV-positive and HIV-negative participants, a…
Matched conditions: SKIN KAPOSI SARCOMA
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC